About BioCelles: Where Legacy Meets Precision Science
Pioneering Tradition Since 1870s | Validating Wisdom with Science Since 1999
For over 150 years, the Hiew familyâdescendants of Jiang Zi Ya (Jiang Tai Gong)âhas preserved and refined ancient herbal knowledge through meticulous documentation and practice. In 1999, our founder Mr. Cae Hiew founded BioCelles to transform this generational legacy into a global mission: to decode and deliver TCMâs natural healing power through precision biotechnology with A.I..
Today, we stand at the convergence of three millennia of herbal wisdom and 21st-century scientific rigor. As a 26-year leader in evidence-based TCM products, we leverage AI, genomics, and systems biology to transform ancestral remedies into targeted, pharmaceutical-grade precision therapeutics.
Our Evolution Synopsized: Past, Present & Future
THE PAST: ROOTED IN ANCIENT WISDOM
- 1870sâ1998: The Hiew familyâs curated, carefully preserved and refined ancient traditional medicine manuscriptsâaccumulated over generationsâenabled holistic healing for communities across Asia. These texts documented organic herbs, ethical wildcrafting, and non-invasive methodologies refined through millennia of observation.
- Enduring Favorite Product: Our foundational formula, SXR / XXR (Shu Xin Ren / Xu Xin Ren / èćżä»), originated from these manuscripts. First commercialized in 1999 by our founder Mr. Cae Hiew, it pioneered natural cardiovascular support with zero reported side effectsâa testament to TCMâs safety and efficacy.
THE PRESENT: SCIENCE-VALIDATED HEALING
- Since 1999: Weâve integrated Biotechnology research protocols with TCM, achieving systematic standardization and organic certification. Our multidisciplinary team (TCM practitioners, molecular biologists, AI specialists) employs:
- Network Pharmacology to map multi-target herb interactions.
- Genomic Analysis to identify bioactive compounds.
- Clinical Feedback Loops to refine formulations.
- All the above were guided by Artificial Intelligence (AI), Machine Learning (ML), Deep Learning (DL), Graph Neural Networks (GNNs) and Natural Language Processing (NLP) to analyse vast amounts of TCM data, identify patterns, and later develop predictive models to improve on diagnosis, treatment, and discovery of new effective and precise traditional medicine through optimisation of our existing herbal formulations.
- SXR / XXR: A 26-Year Validation
- 5th Generation Formula (2025): Enhanced bioavailability targets cardiovascular-cerebrovascular-circulatory system health with unprecedented speed (effects reported in as few as only 2 capsules).
- Proven Impact: Documented cases include normalized D-dimer levels for an 82 years old patient (e.g., 3490 â 725 ng/mL in this elderly patients in 2024) and relief from chronic conditions.
- Global Trust: TCM herbal healing endorsed by leaders like Tun Dr. Mahathir (former Malaysian Prime Minister, who turned 99 years old in 2025) and used across 15+ countries.
THE FUTURE: PRECISION TCM THROUGH BIOTECH
Weâre advancing into Next-Generation Precision Medicine by:- Decoding Mechanisms: Using AI to analyse how TCM compounds interact with human genomics and diseases.
- Predictive Formulations: Developing algorithm-driven herbal synergies for conditions like immune dysregulation, metabolic disorders, and antimicrobial resistance.
- Global Health Security: Creating rapid-response botanical herbal solutions for emerging pathogens (e.g., SARS-CoV-2 variants, superbugs) and mycotoxin mitigation.